Injectable Drug Delivery Market Analysis 2018-Business Growth By key Players, Major Application Survey &Trend Forecast To 2022

According to Research for Markets, the Global Injectable Drug Delivery market is accounted for $348.64 billion in 2015 and is expected to reach $866.31 billion by 2022 growing at a CAGR of 13.9%. Rising incidences of chronic diseases, technological advancements and increase in demand for self injection devices are some of the factors proliferating market demand. However, factors such as needle-stick injuries and lack of access to or failure to use appropriate personal protective equipment are some factors inhibiting the market.

To Buy Now This Report Directly Follow@ http://www.researchformarkets.com/buy-now/injectable-drug-delivery-global-market-4538/one

Oncology and Hormonal disorder segment among therapeutic applications is expected to dominate the market owing to the rising number of patients suffering from diabetes and oncologic disorders. Moreover, self-injection device segment in product type is estimated to be the fastest growing segment on account of growing geriatric people coupled with diabetic patients. North American market is estimated to be the dominant among others attributed to its huge patient base and healthcare sector. Asia Pacific is expected to be the fastest growing market on account of its emerging healthcare sector.

Looking for more information on this market? Request for Free Sample Copy of Report @ http://www.researchformarkets.com/sample/injectable-drug-delivery-global-market-4538

Some of the key players of the Injectable Drug Delivery market include Alkermes PLC, Baxter International, Inc., Becton, Dickinson and Company, Elcam Medical, ELI Lilly and Company, Gerresheimer AG, Novo Nordisk, Pfizer, Inc., Sandoz, Schott AG, Terumo Corporation and Teva Pharmaceutical Industries Ltd.

Therapeutic Applications Covered:

• Autoimmune Diseases
• Crohn’s Disease
• Multiple Sclerosis
• Psoriasis
• Rheumatoid Arthritis
• Other Autoimmune Diseases
• Hormonal Disorders
• Anaemia
• Antithrombotic/Thrombolytic Therapy
• Diabetes
• Growth Hormone Deficiency (GHD)
• Osteoporosis
• Reproductive Health Disease
• Orphan Diseases
• Oncology
• Other Therapeutic Applications
• Pain Management
• Allergy Treatment
• Aesthetic Treatments
• Hepatitis C
• Haemophilia

End-Users Covered:

• Home Care Settings
• Hospitals and Clinics
• Pharmaceutical and Biotechnology Companies
• Research Laboratories
• Other End Users

Types Covered:

• Auto-injectors
• Reusable Auto-injectors
• Disposable Auto-injectors
• Product Specific Auto-injectors
• Pen Injectors
• Custom Pen Designs
• Disposable Pens
• Dual Chamber Pens
• Prefilled Pen Cartridges
• Standardized Pen Platforms
• Needle-free Injectors
• Mass Immunization Injectors
• Prefilled Disposable Models
• Refillable Cartridge Designs
• Energy Source
• Jet-Based Needle-Free Injectors
• Spring-Based Needle-Free Injectors
• Laser-Powered Needle-Free Injectors
• Vibration-Based Needle-Free Injectors
• Prefilled Syringes
• Plastic Prefilled Syringes
• Glass Prefilled Syringes
• Pre-fillable Safety Syringes
• Safety Syringes
• Pre-fillable Integrated Safety Syringes
• Non-Pre-fillable Integrated Safety Syringes
• Conventional Injection Devices

Formulations Covered:

• Novel Drug Delivery Formulations
• Colloidal Dispersions
• Micro particles
• Long-Acting Injection Formulations
• Conventional Drug Delivery
• Solutions
• Reconstituted/Lyophilized Formulations
• Suspensions
• Emulsions

Modes of Administration Covered:

• Central Nervous System
• Circulatory/Musculoskeletal
• Organs
• Skin

Usage Patterns Covered:

• Curative Care
• Immunization
• Other Usage Patterns
• Blood Transfusion & Blood Products
• Contraceptives

What our report offers:

- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Early Buyers Will Receive Instant Discount On This Report @ http://www.researchformarkets.com/discount/injectable-drug-delivery-
global-market-4538

Short review On Table Of Content-

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End-User Analysis
3.8 Product Analysis
3.9 Emerging markets
3.10 Futuristic market scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Injectable Drug Delivery Market, By Therapeutic Application
5.1 Introduction
5.2 Autoimmune Diseases
5.2.1 Crohn’s Disease
5.2.2 Multiple Sclerosis
5.2.3 Psoriasis
5.2.4 Rheumatoid Arthritis
5.2.5 Other Autoimmune Diseases
5.3 Hormonal Disorders
5.3.1 Anaemia
5.3.2 Antithrombotic/Thrombolytic Therapy
5.3.3 Diabetes
5.3.4 Growth Hormone Deficiency (GHD)
5.3.5 Osteoporosis
5.3.6 Reproductive Health Disease
5.4 Orphan Diseases
5.5 Oncology
5.6 Other Therapeutic Applications
5.6.1 Pain Management
5.6.2 Allergy Treatment
5.6.3 Aesthetic Treatments
5.6.4 Hepatitis C
5.6.5 Haemophilia

6 Global Injectable Drug Delivery Market, By End User
6.1 Introduction
6.2 Home Care Settings
6.3 Hospitals and Clinics
6.4 Pharmaceutical and Biotechnology Companies
6.5 Research Laboratories
6.6 Other End Users

7 Global Injectable Drug Delivery Market, By Type
7.1 Introduction
7.2 Auto-injectors
7.2.1 Reusable Auto-injectors
7.2.2 Disposable Auto-injectors
7.2.3 Product Specific Auto-injectors
7.3 Pen Injectors
7.3.1 Custom Pen Designs
7.3.2 Disposable Pens
7.3.3 Dual Chamber Pens
7.3.4 Prefilled Pen Cartridges
7.3.5 Standardized Pen Platforms
7.4 Needle-free Injectors
7.4.1 Mass Immunization Injectors
7.4.2 Prefilled Disposable Models
7.4.3 Refillable Cartridge Designs
7.4.4 Energy Source
7.4.5 Jet-Based Needle-Free Injectors
7.4.6 Spring-Based Needle-Free Injectors
7.4.7 Laser-Powered Needle-Free Injectors
7.4.8 Vibration-Based Needle-Free Injectors
7.5 Prefilled Syringes
7.5.1 Plastic Prefilled Syringes
7.5.2 Glass Prefilled Syringes
7.5.3 Prefillable Safety Syringes
7.6 Safety Syringes
7.6.1 Prefillable Integrated Safety Syringes
7.6.2 Non-Prefillable Integrated Safety Syringes
7.7 Conventional Injection Devices

8 Global Injectable Drug Delivery Market, By Formulations
8.1 Introduction
8.2 Novel Drug Delivery Formulations
8.2.1 Colloidal Dispersions
8.2.1.1 Liposomes
8.2.1.2 Niosomes
8.2.1.3 Polymeric/Mixed Micelles
8.2.1.4 Nanoparticles
8.2.1.4.1 Nanosuspensions
8.2.1.4.2 Nanoemulsions/Microemulsions
8.2.1.4.3 Solid-Lipid Nanoparticles
8.2.2 Microparticles
8.2.2.1 Microspheres
8.2.2.2 Microcapsules
8.3 Long-Acting Injection Formulations
8.4 Conventional Drug Delivery
8.4.1 Solutions
8.4.2 Reconstituted/Lyophilized Formulations
8.4.3 Suspensions
8.4.4 Emulsions

9 Global Injectable Drug Delivery Market, By Mode of Administration
9.1 Introduction
9.2 Central Nervous System
9.3 Circulatory/Musculoskeletal
9.4 Organs
9.5 Skin

10 Global Injectable Drug Delivery Market, By Usage Pattern
10.1 Introduction
10.2 Curative Care
10.3 Immunization
10.4 Other Usage Patterns
10.4.1 Blood Transfusion & Blood Products
10.4.2 Contraceptives

11 Global Injectable Drug Delivery Market, By Geography
11.1 North America
11.1.1 US
11.1.2 Canada
11.1.3 Mexico
11.2 Europe
11.2.1 Germany
11.2.2 France
11.2.3 Italy
11.2.4 UK
11.2.5 Spain
11.2.6 Rest of Europe
11.3 Asia pacific
11.3.1 Japan
11.3.2 China
11.3.3 India
11.3.4 Australia
11.3.5 New Zealand
11.3.6 Rest of Asia Pacific
11.4 Rest of the World
11.4.1 Middle East
11.4.2 Brazil
11.4.3 Argentina
11.4.4 South Africa
11.4.5 Egypt

12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies

13 Company Profiling
13.1 Alkermes PLC
13.2 Baxter International, Inc.
13.3 Becton, Dickinson and Company
13.4 Elcam Medical
13.5 ELI Lilly and Company
13.6 Gerresheimer AG
13.7 Novo Nordisk
13.8 Pfizer, Inc.
13.9 Sandoz
13.10 Schott AG
13.11 Terumo Corporation
13.12 Teva Pharmaceutical Industries Ltd.

If you have any special requirements, please let us know and we will offer you the report as you want.

Know More About our Knowledge store @ http://www.researchformarkets.com/reports/injectable-drug-delivery-global-market-4538

About Us:

Research For Markets indulge in detailed and diligent research on different markets, trends and emerging opportunities in the successive direction to cater to your business needs. We have established the pillars of our flourishing institute on the grounds of Credibility and Reliability. RFM delve into the markets across Asia Pacific, North America, South America, Europe, Middle East And Africa.

Contact Us:

Mr. A Naidu

Research for Markets

Email: alan.naidu@researchformarkets.com

+44 8000-4182-37

This release was published on openPR.